Type 1 Diabetes Mellitus at UDEC

Type1 Diabetes mellitus is an autoimmune disorder.  
Between 0.5 and 1 percent of the population lives with type 1 diabetes.
Originally called juvenile diabetes, it's now known to happen at any age.
Type 1 diabetes can happen to anyone.,
And we believe it should be treated well enough to prevent the misery, suffering and 
premature death traditionally ascribed to people with type 1 diabetes.

People with Type 1 Diabetes must be continually aware of blood glucose level and insulin activity to maintain control and avoid low or high glucose excursions that impair thinking or endanger life.
The knowledge, understanding and experience required to treat type 1 diabetes properly
 doctors with both personal and professional interests in this most complex of disorders.

​

Understanding Insulin

Insulin became available in 1923.  Doctors soon discovered that everyone responds differently to insulin.  A century later we have dozens of insulins, injectable, inhaled, infused and ingested.  Using insulin well remains part science and part utilitarian.  We know insulin better than most endocrinologists, because we've used them and sensed their effects upon well-being.

Additional Treatments in Type 1 Diabetes

People with type 1 diabetes can often employ treatments like GLP-1 agonists and SGLT2 inhibitors to improve and stabilize blood glucose control.  We've studied most of these treatments in type 1 diabetes over many years, and understand when combining treatments can achieve your best health 

Technology in Type 1 diabetes

During the 40 years since insulin pumps first appeared, we've used almost all of them.  Same with the glucose monitors and  in the past two decades, continuous glucose sensors.  New pumps collect glucose data and adjust insulin to control glucose nearly automatically.  Endocrinologists can use pumps well enough to prevent diabetes complications.  We can use them to yield near-normal glucose levels and most importantly, optimal wellbeing. We can recommend the pump, sensor and algorithm to best meet your needs, but instead we consult as you make your own choices.  We don't accept funds from device makers. 

The Future of Type 1 Diabetes 

We eagerly await nascent treatments like stem cell derived islet transplants, beta cell rejuvenation, and immune redirection.  Watch for clinical studies of these treatments as they become useful and safe.

See Some Examples
View More